New hope for kids with stubborn neuroblastoma? trial tests two aggressive therapies

NCT ID NCT03165292

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 27 times

Summary

This study looked at two stronger treatment plans for children with a very high-risk type of nerve cancer called neuroblastoma that did not shrink enough after standard chemotherapy. The goal was to see if these more intense treatments could help children live longer without the cancer coming back. The trial was stopped early and included 34 children from multiple countries.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VERY HIGH RISK NEUROBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Fondazione IRCCS Istituto nazionaleTumori

    Milan, 20133, Italy

  • Gustave Roussy

    Villejuif, Val De Marne, 94805, France

  • Hospital Universitario Cruces

    Cruces, 48903, Spain

  • Hospital Universitario y policnico La Fe

    Valencia, 46026, Spain

  • Medizinische Universität Innsbruck

    Innsbruck, 356020, Austria

  • Meyer children's Hospita

    Florence, 50139, Italy

  • Ospedale Pediatrico Bambino Gesù

    Roma, Italy

  • Princess Maxima Center

    Utrecht, Netherlands

  • St. Anna Kinderspital GmbH

    Vienna, 1090, Austria

Conditions

Explore the condition pages connected to this study.